ZyDoc® Selected to Present at the 26th New York Venture Summit as Clinical Documentation Shifts Back Onshore

ZyDoc® will unveil a two-year roadmap, an industry-first documentation capability, and its onshoring strategy at the New York Venture Summit in November 2026.

NEW YORK, NY, UNITED STATES, September 16, 2026 /EINPresswire.com/ -- ZyDoc^®, the U.S.-based clinical documentation company behind the Hybrid-AI© model and the HIPAA-secure TrackDoc Connect© platform, has been selected to present at the 26th New York Venture Summit, November 18-19, 2026. The summit is presented by youngStartup Ventures and convenes venture capitalists, corporate VCs, angel investors, technology transfer professionals, and emerging growth company executives. A select group of innovators is chosen to present to institutional and strategic investors.

ZyDoc^®'s selection comes as the $14 billion U.S. medical transcription and clinical documentation market shifts back onshore. New federal and state limits on offshore processing of U.S. patient data, along with growing provider fatigue around AI-only scribing tools, are pushing healthcare organizations to re-evaluate where and how their documentation is produced.

"For years this market has treated speed and safety as a tradeoff, and physicians have been the ones paying for it," said James M. Maisel, MD, Founder and CEO of ZyDoc^®. "Our Hybrid-AI approach pairs automation with U.S.-based medical language specialists, which is how we guarantee 99.6% accuracy and deliver EHR-ready notes in under two hours. In New York we will show what that same foundation makes possible on much larger problems."



Corporate Milestones and Industry Recognition

ZyDoc^® has reorganized as ZyDoc^®, Inc., a Delaware C corporation built to support institutional investment and future strategic transactions. Through the transition it kept its key executive team and the core documentation technology it has run in production for years.

ZyDoc^® is an Ai-Med 2025 award winner. That recognition adds to a record that includes a #1 ranking in Customer Service and Support from Black Book Research and multiple national awards for AI-enabled healthcare innovation.

Most recently, ZyDoc^® attended the C3 Davos of Healthcare NYC Summit, held alongside the United Nations General Assembly. Senior health system leaders, investors, clinicians, and policymakers from more than two dozen countries gathered there as AI governance and healthcare data sovereignty move to the center of the global conversation.



An Industry-First Capability and a Two-Year Roadmap

At the summit, ZyDoc^® will present a roadmap that challenges long-standing assumptions in clinical documentation.

It covers three areas:
(1) how clinical data is captured and structured at the point of creation
(2) how interoperability is achieved without lengthy IT projects
(3) how administrative burden is removed for physicians, care teams, staff, and IT organizations at the same time

The presentation will include a first look at a product capability ZyDoc^® believes no other documentation or scribing solution currently offers. It will also include a two-year international expansion roadmap.

That international strategy is built to avoid traditional healthcare offshoring. ZyDoc^® exports its technology, workflow, and operating model, not U.S. patient data. The company is exploring activation opportunities with standing invitations in London and Dubai, with each implementation built around that jurisdiction's data-residency requirements. U.S. healthcare data stays in the U.S., and international data remains within its own regulatory environment.


Turning Onshoring Into a Growth Strategy

A substantial share of U.S. healthcare documentation has historically been processed offshore. As scrutiny of data residency, privacy, cybersecurity, and compliance increases, ZyDoc^® sees an opportunity far larger than competing for individual physician accounts.

The company aims to serve as a U.S.-based conversion platform for established documentation volume that currently depends on offshore operations. Legacy transcription providers facing tighter requirements don't have to lose those customers. They can participate through structured referral, revenue-sharing, acquisition, and strategic arrangements.

Supporting metrics ZyDoc^® will present include:

-Guaranteed 99.6% documentation accuracy
-61% documented productivity improvement in a peer-reviewed usability study
-$100K+ in annual ROI per provider
-EHR-ready notes in under two hours, including STAT workflows
-100% U.S.-based, background-checked workforce
-A $16 to $20 billion total addressable market, with an initial $5.6 billion wedge in procedure-centric specialties


Matt Koerner, MBA Appointed Chief Marketing Officer and Strategic Advisor

ZyDoc^® has appointed Matt Koerner, MBA as Chief Marketing Officer and Strategic Advisor. He will support the company's capital formation and its expansion into targeted in-market niches.

Koerner brings roughly two decades of marketing and growth leadership across healthcare, enterprise, and entertainment. That includes digital health work with the American Medical Association and go-to-market leadership for early and growth-stage health technology companies. He holds a titled appointment as a Scholar for Innovation at the University of Notre Dame, where he worked directly with startups and founders. He is a member of the American College of Healthcare Executives.

"There is a large installed base of U.S. documentation volume that can no longer stay offshore, and it needs somewhere compliant to land," said Koerner. "ZyDoc^® already has the accuracy, the U.S. workforce, and the infrastructure to absorb it, so our first move is conversion. We want to bring established books of business onto the platform instead of winning physician accounts one at a time. From there we go deep in the procedure-centric specialties where documentation directly drives revenue."

"What we're revealing in New York is an industry first, and it addresses physician burden head on," Koerner added. "Today's AI tools make it easy to capture an encounter and produce a note, but in most cases the work lands right back on the physician for final editing and approval. We're a physician-first company, and we're investing our own capital and our own people in this release because the industry deserves something built around the people doing the work. It's already in beta, and it's going to change what the industry expects from this side of the business. Getting to bring it to New York on behalf of physicians and the teams beside them is an honor."


About ZyDoc^®

ZyDoc^® is a U.S.-based clinical documentation company specializing in medical documentation, physician and facility workflow, and healthcare compliance solutions. It serves physician practices, ambulatory surgery centers, and healthcare organizations nationwide. ZyDoc^® combines advanced AI technology with expert U.S.-based human oversight to deliver accurate, secure, workflow-friendly clinical documentation without offshore risk. Learn more at https://www.zydoc.com.

James M. Maisel, M.D.
ZyDoc Medical Transcription, LLC
+ +1 800-546-5633
email us here
Visit us on social media:
LinkedIn
YouTube